stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Starling Oncology, Inc. Common StockSTLN
$6.837.73%0.4902

Starling Oncology, Inc. Common Stock (STLN)

Date: 2026-11-04 16:00O: 6.44H: 7.04L: 6.41C: 6.93Vol: 1.230M
Schlusskurs vom Vortag:
$6.34
Offen:
$6.44
24-Stunden-Volumen:
469,221
Relatives Volumen:
0.37
Marktkapitalisierung:
$696.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.86%
1M Leistung:
+7.56%
6M Leistung:
0.00%
1Y Leistung:
0.00%
1-Tages-Spanne:
$6.41$6.84
1-Wochen-Bereich:
$6.19$6.85
52-Wochen-Spanne:
$4.85$7.13

Starling Oncology, Inc. Common Stock Aktie (STLN) Unternehmensprofil

Firmenname
Starling Oncology, Inc. Common Stock
Telefon
-
Adresse
USA
Mitarbeiter
641
X
-
Nächster Verdiensttermin
2026-11-05
Neueste SEC-Einreichungen
SEC
STLN-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Starling Oncology, Inc. Common Stock Aktie (STLN) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-07-06EingeleitetLake StreetBuy
2025-11-25EingeleitetNeedhamBuy
2025-07-23EingeleitetNoble Capital MarketsOutperform
2025-07-16EingeleitetB. Riley SecuritiesBuy

Finanzdaten der Starling Oncology, Inc. Common Stock-Aktie (STLN)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)502.73393.41324.24252.48203.00
Operating income USD (M)-36.08-60.12-77.02-81.95-45.86
Income before tax USD (M)-60.74-64.66-83.10-0.09-11.60
Income tax expense USD (M)-0.130.00-0.04-0.24-0.67
Net income USD (M)-60.61-64.66-83.070.15-10.93
Basic EPS USD/shares-0.54-0.71-0.920.00-0.16
Diluted EPS USD/shares-0.54-0.71-0.92-0.21-0.16
Basic weighted shares shares (M)92.3975.0473.7572.7966.23
Diluted weighted shares shares (M)92.3975.0473.7580.6166.23
Selling, general and administrative USD (M)105.57107.83113.85119.6983.37

Starling Oncology, Inc. Common Stock-Aktie (STLN) Insiderhandel

  • BRADFORD HIVELYAug 21 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $6.54
    #Aktien
    298,853
    Wert ($)
    1,954,499
    #Aktien Gesamt
    0
  • Hively BradAug 21 '26
    Director
    Transaktion
    Sale
    Kosten
    $6.51
    #Aktien
    298,853
    Wert ($)
    1,946,310
    #Aktien Gesamt
    411,976
  • Chernett JoreyAug 14 '26
    10% Owner
    Transaktion
    Buy
    Kosten
    $6.54
    #Aktien
    12,000
    Wert ($)
    78,480
    #Aktien Gesamt
    10,660,858
  • Chernett JoreyJul 21 '26
    10% Owner
    Transaktion
    Buy
    Kosten
    $5.27
    #Aktien
    18,000
    Wert ($)
    94,860
    #Aktien Gesamt
    10,648,858
  • Podnos YaleJul 14 '26
    Chief Medical Officer
    Transaktion
    Sale
    Kosten
    $6.41
    #Aktien
    23,452
    Wert ($)
    150,340
    #Aktien Gesamt
    259,527
  • YALE PODNOSJul 14 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $6.25
    #Aktien
    23,452
    Wert ($)
    146,575
    #Aktien Gesamt
    0
  • Podnos YaleJul 14 '26
    Chief Medical Officer
    Transaktion
    Option Exercise
    Kosten
    $1.90
    #Aktien
    23,452
    Wert ($)
    44,567
    #Aktien Gesamt
    277,501
  • Chernett JoreyJul 10 '26
    10% Owner
    Transaktion
    Buy
    Kosten
    $5.85
    #Aktien
    15,000
    Wert ($)
    87,750
    #Aktien Gesamt
    10,630,858
  • Chernett JoreyJun 23 '26
    10% Owner
    Transaktion
    Buy
    Kosten
    $5.02
    #Aktien
    18,000
    Wert ($)
    90,360
    #Aktien Gesamt
    10,615,858
  • YALE PODNOSJun 08 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $4.87
    #Aktien
    23,451
    Wert ($)
    114,206
    #Aktien Gesamt
    0
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
BRADFORD HIVELYDirectorAug 21 '26Proposed Sale$6.54298,8531,954,4990
Hively BradDirectorAug 21 '26Sale$6.51298,8531,946,310411,976
Chernett Jorey10% OwnerAug 14 '26Buy$6.5412,00078,48010,660,858
Chernett Jorey10% OwnerJul 21 '26Buy$5.2718,00094,86010,648,858
Podnos YaleChief Medical OfficerJul 14 '26Sale$6.4123,452150,340259,527
YALE PODNOSOfficerJul 14 '26Proposed Sale$6.2523,452146,5750
Podnos YaleChief Medical OfficerJul 14 '26Option Exercise$1.9023,45244,567277,501
Chernett Jorey10% OwnerJul 10 '26Buy$5.8515,00087,75010,630,858
Chernett Jorey10% OwnerJun 23 '26Buy$5.0218,00090,36010,615,858
YALE PODNOSOfficerJun 08 '26Proposed Sale$4.8723,451114,2060

Starling Oncology, Inc. Common Stock Aktie (STLN) Neueste Nachrichten

Nov 03, 2026
Nov 03, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 19, 2026
Oct 19, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 10, 2026
Oct 10, 2026
Oct 07, 2026
Oct 07, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 20, 2026
Sep 20, 2026
Sep 20, 2026
Sep 20, 2026
Sep 14, 2026
Sep 14, 2026
Sep 08, 2026
Sep 08, 2026
Aug 27, 2026
Aug 27, 2026
Aug 24, 2026
Aug 24, 2026
Aug 21, 2026
Aug 21, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 14, 2026
Aug 14, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 08, 2026
Aug 08, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Jul 13, 2026
Jul 13, 2026
Jul 06, 2026
Jul 06, 2026
Jun 24, 2026
Jun 24, 2026
Mar 12, 2026
Mar 12, 2026
Nov 14, 2025
Nov 14, 2025

Ähnlich wie STLN